Product Images Memantine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 23 images provide visual information about the product associated with Memantine NDC 60505-6162 by Apotex Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The given text represents a chart depicting the cumulative percentage of patients using Placebo and Memantine HCI drugs. The chart displays the ADCS-ADL change from the baseline and the scale ranges from -20 to 25. However, the chart does not provide sufficient information to draw any conclusion from it.*
This text appears to be a chart showing the mean change from baseline in ADCS-ADL score for patients given a placebo/donepezil treatment versus memantine HC/donepezil treatment over the course of 12 weeks. The chart includes two categories, "Clinical Improvement" and "Clinical Decline," and displays the values for each treatment option at weeks 2, 4, 6, 8, 10, and 12. No further information is available.*
This text represents a graph showing the mean change from baseline in SIB score over weeks of treatment for two groups. One group received placebo/donepezil and the other received Memantine HCI/Donepezil. The graph indicates that the group receiving the memantine HCI donepezil combination performed better as they experienced less clinical decline over the 24 weeks of treatment.*
The text describes a cumulative percentage of patients with a chart displaying two different treatments: placebo/donepezil and memantine HC/donepezil. The chart shows a line graph with a change from baseline represented by SIB. There are also some numbers on the chart axis.*
This is a description of a medication called Memantine Hydrochloride Oral Solution, manufactured by Apotex Corp. Each 60mL bottle contains 2 mg/mL of memantine hydrochloride. The usual dosage and full prescribing information can be found in the package insert. The medication should be stored at a temperature between 20-25°C (68-77°F) in a tightly closed container. The medication is only available through a prescription and should be kept out of reach of children. The manufacturer is located in Toronto, Ontario, Canada.*
This is a description of a medication called Memantine Hydrochloride Oral Solution manufactured by Apotex Corp. It is designated as B Only and has a concentration of 2g/e. The remaining text is not readable.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.